GUINEA PIG SERUM (sterile)

Katalog-Nummer D105-00-1000

Size : 1L

Marke : Rockland Immunochemicals

Contact local distributor :


Telefonnummer : +1 850 650 7790

Background

Guinea Pig Serum is used as a supplement to cell culture media. Guinea Pig Serum is also suitable for use as a component of bioassays, immunoassays or enzyme assays. Guinea Pig Serum provides a broad spectrum of macromolecules, carrier proteins for lipoid substances and trace elements, attachment and spreading factors, low molecular weight nutrients, and hormones and growth factors that promote cell growth and health. Be certain to maintain Good Cell Culture Practice, and maintain sterility of cultures that require media supplementation. Guinea Pig Serum is ideal for investigators in Cancer, Immunology, and Cell Biology research.

Expand Background

Specifications for Guinea Pig Serum Sterile

Product Details

Guinea Pig Serum (Sterile) - D105-00-0050
Guinea Pig serum for cell culture, cell culture grade guinea pig serum, sterile serum from guinea pig.
Guinea Pig

Application Details

ELISA, FC, IHC, Other, WB, Multiplex  - View References
pH: normal Immunoelectrophoresis: normal Hemoglobin: normal IgG Concentration: normal

Tissue Data

Serum
Mixed
Guinea Pig - Mixed

Formulation

Sterile
Liquid (sterile filtered)
72mg/ml by Refractometry
None
None
None

Shipping & Handling

Dry Ice
Store container at -20° C prior to opening. Avoid cycles of freezing and thawing. Use aseptic technique to maintain sterility when opening product.
Expiration date is one (1) year from date of receipt.

References (34)

(). FoxP3+ regulatory T cells are not important for rotavirus clearance or the early antibody response to rotavirus. Microbes Infect.
Applications
E, EIA
PubMed
(). Safety and immunogenicity of a live oral recombinant cholera vaccine VA1.4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India. PLoS One.
Applications
Other
PubMed
(). Anandamide and Δ9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. J Neuroimmunol.
Applications
Other
PubMed
(). Effects of fatty acid-free bovine serum albumin and fetal calf serum supplementing repair cultures on pre- and post-warm viability of biopsied bovine embryos produced in vitro. J Reprod Dev.
Applications
Other
PubMed
(). T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms. Biol Blood Marrow Transplant.
Applications
FC, FACS, FLOW
PubMed
(). Immunohistochemical distribution of c-Kit-positive cells and nitric oxide synthase-positive nerves in the guinea-pig small intestine. J Auton Nerv Syst.
Applications
IHC, ICC, Histology; Multiplex Assay
PubMed
(). CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells. J Neuroimmunol.
Applications
Undefined
PubMed
(). Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum. Immunopharmacology.
Applications
Other
PubMed
(). Antibody of patients with Guillain-Barré syndrome mediates complement-dependent cytolysis of rat Schwann cells: susceptibility to cytolysis reflects Schwann cell phenotype. J Neuroimmunol.
Applications
Undefined
PubMed
(). Incorporation of a product of mevalonic acid metabolism into proteins of Chinese hamster ovary cell nuclei. J Cell Biol.
Applications
WB, IB, PCA
PubMed
(). Inhibition of antibody production from the plasmacytoma cell line MOPC-315 by staphylococcal enterotoxin B-induced T-suppressor cells. Cell Immunol.
Applications
Undefined
PubMed
(). Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space. J Biol Chem.
Applications
Other
PubMed
(). Translation of human macrophage activating factor (for glucose consumption) mRNA in Xenopus laevis oocytes. Immunol Invest.
Applications
Undefined
PubMed
(). Size distribution and stability of the trans-membrane channels formed by complement complex C5b-9. Mol Immunol.
Applications
Undefined
PubMed
(). Elimination of complement channels from the plasma membranes of U937, a nucleated mammalian cell line: temperature dependence of the elimination rate. J Immunol.
Applications
Undefined
PubMed
(). Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins. J Clin Invest.
Applications
Other
PubMed
(). Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives. Proc Natl Sci USA
Applications
Other
PubMed
(). Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism. Arch Biochem Biophys.
Applications
Undefined
PubMed
(). Size of the transmembrane channels produced by complement proteins C5b-8. J Immunol.
Applications
Undefined
PubMed
(). Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel. Proc Natl Sci USA
Applications
Other
PubMed
(). Immune response gene control of antibody specificity. Cell Immunol.
Applications
Undefined
PubMed
(). Ir gene control of the immune response to insulins. I. Pork insulin stimulates T cell activity in nonresponder mice. J Immunol.
Applications
Undefined
PubMed
(). Life-span and size of the trans-membrane channel formed by large doses of complement. J Immunol.
Applications
Undefined
PubMed
(). Effect of anti-P1A1 antibody on human platelets. I. The role of complement. Blood.
Applications
Other
PubMed
(). T-cell regulation of restricted B-cell responses. Adv Exp Med Biol.
Applications
Undefined
PubMed
(). Impaired granulocyte adherence in multiple myeloma: relationship to complement system, granulocyte delivery, and infection. Blood.
Applications
Other
PubMed
(). Effect of C3b inactivator on monocyte-bound C3-coated human erythrocytes. Blood.
Applications
Other
PubMed
(). Low-dose antigenic signals to helper lymphocytes. Cell Immunol.
Applications
Cell Depletion
PubMed
(). Antigen recognition: the specificity of an isolated T lymphocyte population. J Immunol.
Applications
Undefined
PubMed
(). Immune Ascites in the Guinea Pig: Specificity of Cells and Antibody in an Induced Peritoneal Exudate. J Immunol.
Applications
Undefined
PubMed
(). Down regulation in B lymphocytes: low dose signals. Eur J Cell Biol.
Applications
Cell Depletion
PubMed
(). Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality. Blood.
Applications
IHC, ICC, Histology; Other
PubMed
(). Effect of papain on the interaction between human monocytes, erythrocytes, and IgG. Blood.
Applications
Other
PubMed
(). Shortened Radioimmunoassay for Human Growth Hormone. Clin Chem.
Applications
Undefined
PubMed

Related Protocols

Adherent Cell Lysis Protocol
ELISA Protocol
Flow Cytometry (FC) Protocol
Fluorescent Western Blotting Protocol
Heat-induced Antigen Retrieval Protocol
Histone Immunoblotting Protocol
Immunohistochemistry (IHC) Protocol
In-Cell Western (ICW) Protocol
IP-WB with TrueBlot® Protocol
Multi-Lysate Western Blotting Protocol
Nuclear & Cytoplasmic Extract Protocol
Protease-induced Antigen Retrieval Protocol
Sandwich ELISA Protocol for Collagen
Staining Paraffin Sections by PAP Procedure
Suspension Cultured Cell Lysis Protocol
Western Blotting (WB) Protocol

Certificate of Analysis Lookup

Invalid lot number

Search

If you need help finding your CoA, contact us

Disclaimer

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.